Advice on newborn blood spot testing for SCID
Intended for healthcare professionals
Opinion Previous     Next

Advice on newborn blood spot testing for SCID

Erin Dean Health writer

Screening for severe combined immunodeficiency is being tested as part of a newborn blood spot testing programme

Severe combined immunodeficiency (SCID) is a is a group of rare inherited conditions that impair the development of the immune system, leading to reduced numbers of and malfunctioning T and B lymphocytes, which are white blood cells made in the bone marrow and thymus gland to fight infection. This means that illnesses that are not serious for most babies can be life-threatening for infants with SCID. Without early recognition and treatment, babies with SCID generally die before one year of age.

Nursing Children and Young People. 33, 6, 16-17. doi: 10.7748/ncyp.33.6.16.s7

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more